Atlanticare Regional Medical Center

Atlanticare Regional Medical Center was paid $214.91M by Medicaid between Jan 2018 and Dec 2024, across 449 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.

33Billing provider infoATLANTICARE REGIONAL MEDICAL CENTER
POMONA, NJ 08240

33aNPI1013919315assigned 06/01/2005

33bProvider typeGeneral Acute Care Hospital

28Total paid$214.91M

24GClaims2,683,355

24DCodes billed449

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#6 of 93

Median peer was paid$30.60M

This provider vs. median7.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	388,369	$36.38M
2019	370,563	$33.16M
2020	311,801	$25.23M
2021	341,227	$26.63M
2022	434,954	$33.77M
2023	447,504	$33.83M
2024incomplete	388,937	$25.90M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	23%	130,701	117,315	$48.52M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	21%	99,901	89,103	$45.31M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	10%	57,361	49,035	$21.66M
G0378	Hospital observation service, per hour	6.9%	30,276	21,333	$14.72M
H0035	Mental health partial hospitalization, treatment, less than 24 hours	3.7%	25,089	2,845	$7.90M
A0427	Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)	2.9%	21,220	19,607	$6.32M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.8%	30,424	28,483	$5.95M
S9480	Intensive outpatient psychiatric services, per diem	2.5%	6,409	5,761	$5.27M
59025	Fetal non-stress test	1.6%	7,043	3,204	$3.53M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.4%	12,752	12,213	$2.97M
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	1.3%	14,238	11,865	$2.80M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	5,616	5,548	$2.11M

437 more codes

70450	Computed tomography, head or brain; without contrast material	<1%	19,752	$2.01M
A0425	Ground mileage, per statute mile	<1%	44,023	$1.98M
A0434	Specialty care transport (sct)	<1%	3,686	$1.75M
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	7,890	$1.44M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	3,935	$1.33M
96375	Therapeutic injection; each additional sequential IV push	<1%	23,056	$1.25M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	680	$1.22M
OP250		<1%	392,842	$1.20M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,449	$1.15M
41899	Unlisted procedure, dentoalveolar structures	<1%	410	$1.15M
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	7,905	$1.03M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	5,622	$1.02M
77067	Screening mammography, bilateral, including computer-aided detection	<1%	7,283	$920K
76801		<1%	9,646	$907K
OP370		<1%	6,543	$830K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	50,270	$784K
90935	Hemodialysis procedure with single evaluation by a physician	<1%	1,501	$749K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,742	$708K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	7,198	$674K
71046	Radiologic examination, chest; 2 views	<1%	36,475	$660K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	7,174	$655K
OP710		<1%	8,056	$642K
72125	Computed tomography, cervical spine; without contrast material	<1%	6,033	$637K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	787	$607K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	22,520	$603K
76830	Ultrasound, transvaginal	<1%	6,465	$566K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	5,959	$555K
76813		<1%	3,836	$554K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	6,697	$493K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	103,355	$488K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	37,232	$475K
93017		<1%	1,649	$469K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	16,743	$465K
93970		<1%	3,532	$465K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,406	$435K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,305	$429K
93971		<1%	3,524	$422K
J9271	Injection, pembrolizumab, 1 mg	<1%	38	$402K
80048	Basic metabolic panel (calcium, ionized)	<1%	110,592	$381K
77063	Screening digital breast tomosynthesis, bilateral	<1%	6,684	$377K
70486		<1%	2,325	$366K
96361	Intravenous infusion, hydration; each additional hour	<1%	4,107	$353K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	20,108	$340K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,139	$311K
OP272		<1%	8,268	$299K
71045	Radiologic examination, chest; single view	<1%	21,634	$292K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	1,331	$282K
71250		<1%	1,596	$264K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	8,628	$263K
76770		<1%	2,463	$261K
77066	Tomosynthesis, mammo	<1%	1,301	$235K
80053	Comprehensive metabolic panel	<1%	21,459	$234K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	17,117	$223K
76642		<1%	2,467	$222K
97597		<1%	974	$218K
93976		<1%	1,229	$213K
77336		<1%	1,891	$210K
A0433	Advanced life support, level 2 (als 2)	<1%	565	$206K
77412		<1%	2,680	$202K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	448	$200K
78815	Positron emission tomography (PET) for limited area imaging	<1%	150	$197K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	665	$184K
G0177	Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more)	<1%	2,650	$182K
93458		<1%	124	$178K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,133	$178K
72100		<1%	5,283	$173K
96417		<1%	605	$161K
73562		<1%	6,619	$154K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	2,512	$150K
A0998	Ambulance response and treatment, no transport	<1%	777	$146K
77065	Tomosynthesis, mammo	<1%	1,184	$141K
A0428	Ambulance service, basic life support, non-emergency transport, (bls)	<1%	7,433	$140K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	11,125	$132K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	2,380	$131K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	10,624	$130K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,454	$130K
87428		<1%	13,277	$128K
99214	Doctor's office visit, returning patient (more involved)	<1%	9,286	$125K
73630		<1%	6,227	$125K
96415		<1%	327	$124K
90791	Psychiatric diagnostic evaluation	<1%	4,349	$120K
76536		<1%	1,051	$119K
J2406	Injection, oritavancin (kimyrsa), 10 mg	<1%	120	$117K
73030		<1%	4,952	$116K
OP270		<1%	8,963	$115K
80320		<1%	7,411	$114K
36415	Collection of venous blood by venipuncture	<1%	40,165	$111K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	1,212	$109K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	13,517	$108K
73130		<1%	5,117	$107K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	12,392	$102K
73610		<1%	5,479	$100K
76818		<1%	660	$98K
72131		<1%	693	$98K
77080		<1%	1,015	$94K
84484		<1%	30,945	$94K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	3,816	$92K
OP379		<1%	2,045	$90K
76376		<1%	3,443	$89K
94060		<1%	265	$84K
76857		<1%	2,291	$84K
76870		<1%	1,231	$82K
85027		<1%	33,290	$80K
74022		<1%	4,137	$79K
99213	Doctor's office visit, returning patient (routine)	<1%	7,498	$79K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	1,551	$76K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	7,879	$75K
84443	Thyroid stimulating hormone (TSH)	<1%	7,431	$75K
70491		<1%	434	$73K
J1815	Injection, insulin, per 5 units	<1%	5,235	$71K
82948		<1%	42,395	$71K
10060		<1%	1,645	$70K
58558		<1%	26	$68K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	1,158	$66K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	7,879	$66K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,021	$65K
85610		<1%	23,008	$64K
84703		<1%	56,008	$64K
73110		<1%	2,985	$62K
80076		<1%	29,033	$60K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	541	$57K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	840	$57K
74018		<1%	3,051	$56K
82077		<1%	11,311	$53K
71271		<1%	558	$53K
J7030	Infusion, normal saline solution , 1000 cc	<1%	47,581	$53K
76820		<1%	682	$52K
72040		<1%	1,958	$52K
77334		<1%	99	$52K
93880		<1%	257	$51K
12001		<1%	1,276	$50K
G0410	Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes	<1%	1,244	$48K
90715		<1%	5,147	$48K
99215	Doctor's office visit, returning patient (complex)	<1%	3,285	$48K
93460		<1%	30	$46K
81001		<1%	53,362	$43K
73502		<1%	2,407	$42K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	30,826	$40K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	535	$39K
J2785	Injection, regadenoson, 0.1 mg	<1%	270	$39K
94644		<1%	2,505	$38K
73080		<1%	1,856	$37K
C1769	Guide wire	<1%	1,790	$36K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	2,092	$35K
12011		<1%	924	$34K
J2704	Injection, propofol, 10 mg	<1%	8,231	$33K
83690		<1%	25,992	$32K
J1644	Injection, heparin sodium, per 1000 units	<1%	9,849	$32K
71101		<1%	1,609	$31K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	37	$31K
76775		<1%	379	$31K
80061	Lipid panel	<1%	4,589	$30K
83735		<1%	17,614	$30K
96376		<1%	2,759	$28K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	419	$28K
85007		<1%	10,007	$27K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	15,924	$26K
73590		<1%	1,477	$25K
87631		<1%	1,008	$25K
87070		<1%	9,354	$25K
83880		<1%	4,654	$24K
86703		<1%	1,356	$24K
70498		<1%	183	$24K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	27,276	$24K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	32	$24K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	2,617	$23K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	8,598	$23K
83036	Hemoglobin; glycosylated (A1C)	<1%	7,227	$23K
70496		<1%	142	$23K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	4,552	$22K
84702		<1%	5,609	$22K
85730		<1%	12,861	$22K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	2,075	$21K
95819		<1%	89	$21K
J0882	Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)	<1%	481	$20K
94729		<1%	255	$20K
83605		<1%	6,050	$20K
73140		<1%	1,722	$20K
73090		<1%	1,102	$19K
86900		<1%	6,459	$19K
87186		<1%	3,484	$19K
86885		<1%	5,519	$19K
80047		<1%	6,725	$19K
29515		<1%	1,162	$18K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	1,090	$18K
49083		<1%	81	$18K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	8,058	$18K
J0897	Injection, denosumab, 1 mg	<1%	25	$18K
29125		<1%	1,435	$18K
J0185	Injection, aprepitant, 1 mg	<1%	137	$17K
77290		<1%	70	$17K
82805		<1%	4,259	$17K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	23	$16K
12002		<1%	478	$16K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	7,315	$16K
97161		<1%	1,536	$16K
72052		<1%	179	$16K
J2060	Injection, lorazepam, 2 mg	<1%	6,758	$16K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,123	$15K
82728		<1%	1,876	$15K
86787		<1%	648	$15K
81003		<1%	15,319	$15K
87086	Culture, bacterial; quantitative colony count, urine	<1%	5,736	$15K
87077		<1%	3,711	$15K
87088		<1%	8,992	$15K
77300		<1%	45	$14K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	2,300	$14K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	9,708	$14K
94727		<1%	227	$13K
84100		<1%	7,979	$13K
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,156	$13K
82550		<1%	6,420	$13K
J7050	Infusion, normal saline solution, 250 cc	<1%	4,278	$13K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	313	$13K
99205	Prolong outpt/office vis	<1%	679	$12K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	5,721	$12K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	7,851	$12K
J1953	Injection, levetiracetam, 10 mg	<1%	1,299	$11K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	3,445	$11K
86901		<1%	6,467	$11K
87040		<1%	3,159	$11K
86803		<1%	767	$11K
72070		<1%	376	$11K
99204	Doctor's office visit, new patient (more involved)	<1%	815	$11K
J1270	Injection, doxercalciferol, 1 mcg	<1%	579	$11K
80329		<1%	408	$10K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	10,037	$10K
84145		<1%	2,958	$10K
96523		<1%	108	$10K
99203	Doctor's office visit, new patient (routine)	<1%	758	$10K
88304		<1%	853	$10K
82607		<1%	1,626	$10K
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	2,887	$10K
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	1,430	$10K
95816		<1%	15	$10K
86710		<1%	4,404	$10K
76000		<1%	472	$9K
85380		<1%	6,714	$9K
93571		<1%	13	$9K
J1170	Injection, hydromorphone, up to 4 mg	<1%	4,854	$9K
74174		<1%	58	$9K
70360		<1%	457	$9K
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	<1%	181	$9K
74246		<1%	57	$8K
J1756	Injection, iron sucrose, 1 mg	<1%	389	$8K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	571	$8K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	1,282	$8K
96411		<1%	45	$8K
74247		<1%	42	$8K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	147	$8K
76819	Fetal biophysical profile; without non-stress testing	<1%	70	$7K
72141		<1%	26	$7K
31505		<1%	261	$7K
73560		<1%	177	$7K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	1,181	$7K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,847	$7K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	900	$7K
83540		<1%	1,911	$7K
J1630	Injection, haloperidol, up to 5 mg	<1%	3,092	$6K
73564		<1%	264	$6K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	115	$6K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	358	$6K
74183		<1%	16	$6K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,046	$6K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	7,877	$6K
87205		<1%	1,912	$6K
74019		<1%	351	$6K
83519		<1%	1,342	$6K
80164		<1%	426	$6K
96367		<1%	379	$5K
87641		<1%	286	$5K
OP279		<1%	1,897	$5K
82746		<1%	920	$5K
78582		<1%	78	$5K
36430		<1%	369	$5K
97162		<1%	437	$5K
93325		<1%	12	$5K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	7,523	$4K
C9113	Injection, pantoprazole sodium, per vial	<1%	1,933	$4K
99201		<1%	396	$4K
97116		<1%	1,313	$4K
58300		<1%	147	$4K
83615		<1%	927	$4K
86140		<1%	4,223	$4K
99152		<1%	403	$4K
82553		<1%	1,229	$4K
83020		<1%	633	$4K
78580		<1%	64	$3K
90792	Psychiatric diagnostic evaluation with medical services	<1%	102	$3K
84550		<1%	617	$3K
84439		<1%	1,031	$3K
OP278		<1%	44	$3K
72110		<1%	43	$3K
84144		<1%	168	$3K
88341		<1%	74	$3K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	173	$3K
88307		<1%	174	$3K
J0690	Injection, cefazolin sodium, 500 mg	<1%	2,884	$3K
OP258		<1%	1,676	$3K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	473	$3K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,089	$3K
88342		<1%	497	$3K
82248		<1%	527	$3K
S9484	Crisis intervention mental health services, per hour	<1%	160	$3K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	3,185	$3K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	101	$2K
73552		<1%	197	$2K
11981		<1%	26	$2K
90375		<1%	12	$2K
72128		<1%	27	$2K
84132		<1%	1,650	$2K
86706		<1%	232	$2K
87340		<1%	1,069	$2K
82330		<1%	772	$2K
85045		<1%	912	$2K
72170		<1%	170	$2K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	87	$2K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	46	$2K
73060		<1%	90	$2K
86762		<1%	726	$2K
84156		<1%	977	$2K
A9540	Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries	<1%	151	$2K
88312		<1%	594	$2K
72072		<1%	145	$1K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	512	$1K
J1940	Injection, furosemide, up to 20 mg	<1%	1,022	$1K
86923		<1%	220	$1K
99153	Mod sedat endo service >5yrs	<1%	85	$1K
82274		<1%	980	$1K
85651		<1%	1,909	$1K
36600		<1%	167	$1K
90686		<1%	175	$1K
94726		<1%	16	$1K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	811	$1K
86756		<1%	804	$1K
J0290	Injection, ampicillin sodium, 500 mg	<1%	510	$1K
86480		<1%	29	$991.60
83970		<1%	123	$989.55
OP255		<1%	1,648	$970.66
M0247	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring	<1%	56	$864.45
80074		<1%	76	$857.98
88173		<1%	25	$816.00
73523		<1%	13	$807.58
97535	Self-care/home management training, each 15 minutes	<1%	241	$801.61
OP271		<1%	105	$766.75
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	320	$754.13
A9558	Xenon xe-133 gas, diagnostic, per 10 millicuries	<1%	78	$744.55
90675		<1%	34	$739.52
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	571	$720.67
80305		<1%	55	$666.48
J3480	Injection, potassium chloride, per 2 meq	<1%	509	$656.84
82150		<1%	280	$629.65
U0001	Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel	<1%	76	$615.52
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	<1%	403	$596.44
J2471	Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg	<1%	367	$580.88
29505		<1%	40	$545.26
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	782	$532.52
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	27	$527.72
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	134	$500.88
76937		<1%	80	$478.41
82378		<1%	31	$461.09
86708		<1%	39	$456.00
82570		<1%	695	$448.59
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	46	$433.49
J3411	Injection, thiamine hcl, 100 mg	<1%	251	$425.40
85576		<1%	12	$408.12
86704		<1%	29	$405.00
0031A		<1%	19	$398.73
86780		<1%	124	$368.61
82043		<1%	368	$363.06
86592		<1%	1,323	$343.71
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	459	$340.59
12013		<1%	16	$323.18
Q0247	Injection, sotrovimab, 500 mg	<1%	55	$307.95
J2305	Injection, nitroglycerin, 5 mg	<1%	98	$302.79
29130		<1%	57	$285.65
96368		<1%	19	$284.00
J8540	Dexamethasone, oral, 0.25 mg	<1%	443	$275.69
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	<1%	99	$273.38
83550		<1%	40	$273.06
J3486	Injection, ziprasidone mesylate, 10 mg	<1%	13	$249.34
J1790	Injection, droperidol, up to 5 mg	<1%	222	$247.78
85347		<1%	155	$242.74
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	557	$233.32
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	246	$232.55
97165		<1%	24	$199.74
J0703	Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg	<1%	94	$190.91
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	462	$180.14
84481		<1%	26	$165.50
82803		<1%	40	$165.00
87493		<1%	24	$163.01
97166		<1%	34	$154.02
J0736	Injection, clindamycin phosphate, 300 mg	<1%	18	$144.45
82947		<1%	808	$129.19
73660		<1%	30	$129.09
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	509	$104.33
85384		<1%	24	$96.00
94660		<1%	16	$85.50
82950		<1%	26	$78.00
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	114	$74.57
82108		<1%	16	$73.74
86308		<1%	119	$68.02
84295		<1%	605	$50.60
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	471	$48.92
83930		<1%	65	$47.61
82310		<1%	122	$44.98
80202		<1%	40	$43.32
J1171	Injection, hydromorphone, 0.1 mg	<1%	89	$42.99
87045		<1%	25	$40.65
82435		<1%	543	$34.85
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	140	$32.70
90656		<1%	19	$32.10
J0780	Injection, prochlorperazine, up to 10 mg	<1%	24	$31.44
82140		<1%	51	$31.13
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	47	$30.91
J0572	Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine	<1%	15	$26.49
J1836	Injection, metronidazole, 10 mg	<1%	20	$22.44
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	86	$19.42
84520		<1%	154	$16.50
J3360	Injection, diazepam, up to 5 mg	<1%	42	$8.32
J0456	Injection, azithromycin, 500 mg	<1%	24	$7.93
88300		<1%	18	$7.23
88302		<1%	14	$5.34
Q0244	Injection, casirivimab and imdevimab, 1200 mg	<1%	88	$5.00
84300		<1%	17	$4.05
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	301	$3.37
J7070	Infusion, d5w, 1000 cc	<1%	12	$3.32
90585		<1%	20	$3.00
91303		<1%	18	$1.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	783	$0.01
G0237	Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring)	0%	23	$0.00
OP911		0%	31	$0.00
90472	Immunization administration, each additional vaccine (list separately)	0%	13	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	202	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	100	$0.00
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	0%	857	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKIM, HAK (EVP AND CFO)